We are live on
!
Find out more
SC
Samlyn Capital Portfolio holdings
AUM
$5.86B
1-Year Est. Return
36.3%
This Fund
S&P 500
This Quarter
Est. Return
+7.1%
1 Year Est. Return
+36.3%
3 Year Est. Return
+115.4%
5 Year Est. Return
+175.71%
10 Year Est. Return
+881.8%
AUM
$4.31B
AUM Growth
-$104M
(-2.4%)
Cap. Flow
-$357M
Cap. Flow
% of AUM
-8.28%
Top 10 Holdings %
Top 10 Hldgs %
23.96%
Holding
178
New
60
Increased
32
Reduced
40
Closed
44
Top Buys
| 1 |
TWX
Time Warner Inc
TWX
|
+$102M |
| 2 |
Biogen
BIIB
|
+$77.9M |
| 3 |
McDonald's
MCD
|
+$63.3M |
| 4 |
Lowe's Companies
LOW
|
+$58.4M |
| 5 |
SEE
Sealed Air
SEE
|
+$47.8M |
Top Sells
| 1 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$118M |
| 2 |
Ferrari
RACE
|
+$81.7M |
| 3 |
Constellation Brands
STZ
|
+$77.4M |
| 4 |
AGN
Allergan plc
AGN
|
+$72.2M |
| 5 |
Amgen
AMGN
|
+$67M |
Sector Composition
| 1 | Financials | 20.36% |
| 2 | Healthcare | 17.35% |
| 3 | Consumer Discretionary | 16.78% |
| 4 | Industrials | 7.92% |
| 5 | Consumer Staples | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Capri Holdings
CPRI
$1.94B
| $8.72M | 0.2% |
+228,921
| New | +$9.01M |
|
|
FMSA
102
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $8.39M | 0.19% |
1,145,000
-114,000
| -9% | -$1.19M |
|
103
Expedia Group
EXPE
$32.5B
| $7.79M | 0.18% |
61,713
-456,295
| -88% | -$55.7M |
|
104
eBay
EBAY
$49.2B
| $7.7M | 0.18% |
+229,335
| New | +$7.46M |
|
|
IPXL
105
DELISTED
Impax Laboratories, Inc.
IPXL
| $7.18M | 0.17% |
+568,000
| New | +$6.86M |
|
106
Citizens Financial Group
CFG
$31.5B
| $7.17M | 0.17% |
+207,600
| New | +$7.58M |
|
107
Radian Group
RDN
$5.2B
| $7.05M | 0.16% |
+392,500
| New | +$7.26M |
|
108
Costco
COST
$419B
| $7.04M | 0.16% |
41,981
-33,458
| -44% | -$5.61M |
|
109
Sarepta Therapeutics
SRPT
$1.82B
| $6.93M | 0.16% |
+234,300
| New | +$7.25M |
|
110
CALL
Brown-Forman Class B
BF.B
$11.9B
| $6.93M | 0.16% |
+234,375
| New | +$6.97M |
|
111
Nike
NKE
$66.1B
| $6.39M | 0.15% |
+114,606
| New | +$6.33M |
|
112
Texas Roadhouse
TXRH
$13B
| $6.07M | 0.14% |
+136,281
| New | +$6.13M |
|
|
ALXN
113
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.98M | 0.14% |
49,300
+15,300
| +45% | +$1.97M |
|
114
PUT
Coca-Cola
KO
$365B
| $5.73M | 0.13% |
+135,000
| New | +$5.63M |
|
|
ITCI
115
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.5M | 0.13% |
+338,500
| New | +$4.9M |
|
116
Alibaba
BABA
$282B
| $5.12M | 0.12% |
+47,451
| New | +$4.83M |
|
117
Essent Group
ESNT
$6.11B
| $5.04M | 0.12% |
+139,300
| New | +$4.84M |
|
118
CALL
Sensata Technologies
ST
$6.46B
| $5.02M | 0.12% |
115,000
-35,000
| -23% | -$1.47M |
|
|
DERM
119
DELISTED
Dermira, Inc.
DERM
| $4.98M | 0.12% |
146,000
+19,000
| +15% | +$613K |
|
120
Vertex Pharmaceuticals
VRTX
$123B
| $4.93M | 0.11% |
45,112
-6,888
| -13% | -$606K |
|
|
NVRO
121
DELISTED
NEVRO CORP.
NVRO
| $4.42M | 0.1% |
47,191
-6,809
| -13% | -$617K |
|
122
Acadia Pharmaceuticals
ACAD
$4.39B
| $4.33M | 0.1% |
+125,800
| New | +$4.44M |
|
123
Abercrombie & Fitch
ANF
$4.33B
| $4.3M | 0.1% |
+360,089
| New | +$4.29M |
|
124
Dollar General
DG
$28B
| $4.08M | 0.09% |
58,474
-618,121
| -91% | -$45.3M |
|
|
SAGE
125
DELISTED
Sage Therapeutics
SAGE
| $4.03M | 0.09% |
56,700
-25,300
| -31% | -$1.48M |
|
Similar funds
LIP
JSSH
CIC
BSL
MWM
TCM
VAM
WAM
Samlyn Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Samlyn Capital held 178 positions worth $4.31B, down 2.4% from $4.41B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Samlyn Capital withdrew a net $357M in Q1 2017, closing 44 positions and reducing 40 holdings. Its most notable exit was TD Ameritrade Holding Corp, an estimated $118M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Samlyn Capital opened a new position in Time Warner Inc worth $103M.
- Samlyn Capital's largest Q1 2017 buy was Time Warner Inc: 1,056,500 shares worth $103M.
- Samlyn Capital added most to Biogen in Q1 2017, an estimated $77.9M increase.
- Samlyn Capital's biggest Q1 2017 reduction was Ferrari, cutting an estimated $81.7M.
- Samlyn Capital fully exited TD Ameritrade Holding Corp in Q1 2017, selling an estimated $118M.
- Samlyn Capital's ten largest holdings make up 24% of its $4.31B portfolio in Q1 2017.
- Samlyn Capital opened 60 new positions and closed 44 in Q1 2017.
- Samlyn Capital's portfolio value fell 2.4% quarter-over-quarter to $4.31B.
Based on Samlyn Capital's 13F filing for Q1 2017, filed 15 May 2017.